Aarti Pharmalabs Limited (AARTIPHARM.NS) Financials

AARTIPHARM.NS Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 ? ?
2023-09-30 23.1 billion 6.6 billion
2023-06-30 ? ?
2023-03-31 22.3 billion 6.7 billion

AARTIPHARM.NS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 375.4 million ?
2023-09-30 362.8 million ?
2023-06-30 344.0 million ?
2023-03-31 702.4 million ?

AARTIPHARM.NS Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 527.6 million
2023-09-30 518.0 million
2023-06-30 470.9 million
2023-03-31 588.4 million

AARTIPHARM.NS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 - - -
2023-09-30 1.2 billion - -
2023-06-30 - - -
2023-03-31 989.9 million - 5.3 million

AARTIPHARM.NS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 90.7 million
2023-09-30 90.6 million
2023-06-30 90.6 million
2023-03-31 90.6 million

AARTIPHARM.NS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - - - -
2023-09-30 - - - -
2023-06-30 - - - -
2023-03-31 331.5 million - 18.4 million 143.0 million

AARTIPHARM.NS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 4.5 billion 2.4 billion
2023-09-30 4.4 billion 2.5 billion
2023-06-30 4.6 billion 2.7 billion
2023-03-31 4.9 billion 1.2 billion

AARTIPHARM.NS

Price: ₹614

52 week price:
275.10
618.05

Earnings Per Share: 21.46 INR

P/E Ratio: 23.09

Exchange: NSI

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 41.0 billion

Links: